Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02362737
Other study ID # AD-1403-11098
Secondary ID
Status Active, not recruiting
Phase N/A
First received January 30, 2015
Last updated August 2, 2017
Start date January 2015
Est. completion date June 30, 2018

Study information

Verified date August 2017
Source Gramercy Research Group
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will test ways to improve health behaviors using an intervention that has been specially designed for African-American men. The program, called Active & Healthy Brotherhood (AHB), will provide information on basic health, and healthy eating, physical activity, stress management, and how to get medical care when needed.The AHB intervention will be compared to a control group that will receive basic health information in videos and brochures.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 332
Est. completion date June 30, 2018
Est. primary completion date July 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 21 Years to 64 Years
Eligibility Inclusion Criteria:

1. AA (based on self-report)

2. self-reported male

3. aged at least 21 years

4. non-institutionalized (i.e., community-dwelling, not living in assisted living facilities, nursing homes, etc.)

5. at high risk for developing chronic disease (e.g., not meeting current guidelines for PA and/or F&V intake; current smoker; diagnosed with high cholesterol) or

6. currently diagnosed with diabetes, hypertension, or cardiovascular disease

7. residents of Forsyth County, NC (or surrounding areas and able to attend group sessions in Forsyth County).

Exclusion Criteria:

1. have had a cardiovascular procedure (e.g., heart surgery), heart attack, heart failure, stroke in the last 6 months

2. have cognitive, visual, auditory, physical functional (e.g., unable to walk unassisted), or language impairment precluding participation in group discussion, learning activities, or data collection.

3. currently achieve >150 min/wk of moderate intensity PA or >75 min/wk of vigorous intensity PA AND currently consume > 9 servings of F&V daily.

4. are currently enrolled in a chronic disease management program.

5. are unwilling to accept randomization assignment or planning to move from local area in <2 years.

6. are currently receiving chemotherapy/radiation treatments.

Participants will be required to obtain approval from a health care provider prior to participation in the study if they:

1. are unable to participate in moderate PA due to physical limitations as indicated by positive (risk) responses on the PA Readiness Questionnaire (PAR-Q) and/or physician disapproval on the PAR Medical Examination.

2. have BP>180/>110 and/or HbA1C>12 and/or triglycerides >500.

3. have health conditions that could preclude changes to diet (e.g., irritable bowel syndrome, celiac disease)

Study Design


Intervention

Behavioral:
Active and Healthy Brotherhood (AHB)
Participants will attend group sessions led by trained group facilitators. The group sessions will be ~16 weekly meetings of ~90 minutes duration for 4 months. AHB participants will also engage in experiential learning opportunities. Following the intensive intervention phase, during months 5 and 6, participants will receive three structured, individual phone calls with the group facilitator.

Locations

Country Name City State
United States Gramercy Research Group Winston-Salem North Carolina

Sponsors (6)

Lead Sponsor Collaborator
Gramercy Research Group Arizona State University, Patient-Centered Outcomes Research Institute, Project Brotherhood, University of North Carolina, Chapel Hill, Vanderbilt University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change activity behavior (minutes per week in Total physical activity (PA) and light, moderate, vigorous PA). Minutes per week in Total physical activity (PA) and light, moderate, vigorous PA baseline, 6 months, 12 months
Primary Change sedentary behavior (minutes per week of sedentary behavior). Minutes per week of sedentary behavior baseline, 6 months, 12 months
Primary Change dietary intake (Fruit and vegetable servings, % fat, sodium and fiber intake). Fruit and vegetable servings, % fat, sodium and fiber intake baseline, 6 months, 12 months
Primary Change stress management. Identification of issues and strategies that affect stress management baseline, 6 months, 12 months
Primary Change help-seeking behaviors (Medication adherence and doctor/ER visits). Medication adherence and doctor/ER visits baseline, 6 months, 12 months
Secondary Change blood pressure. baseline, 6 months, 12 months
Secondary Change body weight. baseline, 6 months, 12 months
Secondary Change blood glucose. baseline, 6 months, 12 months
Secondary Change HbA1c. baseline, 6 months, 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2